Golden Recursion Inc. logoGolden Recursion Inc. logo
Advanced Search
IQVIA

IQVIA

IQVIA is a clinical Research founded in 1998 by Dennis Gillings.

IQVIA is a world leader in using data, technology, advanced analytics, and expertise to help customers drive healthcare forward. Together with the companies we serve, we are enabling a more modern and effective healthcare system and creating breakthrough solutions that transform business and patient outcomes.

IQVIA Connected Intelligence™ is our approach to helping customers drive healthcare forward in this challenging, fast-paced environment. By making intelligent connections between our customers’ needs, our capabilities, and the evolving healthcare ecosystem, we help customers accelerate results, improve patient outcomes, and unleash new opportunities.

Timeline

Patents

Further Resources

Title
Author
Link
Type
Date

LaunchPad - IQVIA

Web

News

Title
Author
Date
Publisher
Description
Kyle LaHucik
September 9, 2021
FierceBiotech
Contract research services provider IQVIA is partnering with research organization HealthCore on real-world data to increase quality and efficiency of clinical research.
Kyle LaHucik
September 7, 2021
FierceBiotech
It's lucky number seven for Medable. The decentralized clinical trials technology company has hired MaryAnne Rizk, Ph.D., as chief strategy officer to lead global partnerships in a year filled with executive snags.
Kyle LaHucik
September 1, 2021
FierceBiotech
Contract research service provider IQVIA is rolling out artificial intelligence to help its team of human agents respond to consumer, patient and healthcare professional inquiries about new products and related therapies and to monitor product quality and safety.
Kyle LaHucik
July 21, 2021
FierceBiotech
Clinical research services provider IQVIA is partnering with respiratory health research hub BREATHE to use health data for early diagnosis of respiratory conditions, accelerate potential personalized treatments, potentially open pathways for long COVID treatment and also attract more Big Pharma and biotech investment in the UK.
Marc Ambasna-Jones
June 28, 2021
ComputerWeekly.com
We explore how the Covid-19 pandemic has forced businesses to rip out traditional paper processes and replace them with end-to-end digitisation
SHOW MORE

References

Golden logo
By using this site, you agree to our Terms & Conditions.